Jun Kubota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jun Kubota has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Kazuya Koizumi
Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
6 shared publicationsMakomo Makazu
Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
6 shared publications- Chikamasa Ichita
Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan
5 shared publications Karen Kimura
Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
5 shared publications- Karen Kimura
Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Japan
5 shared publications - Sakue Masuda
Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Japan
5 shared publications
Latest Publications
- 10 April 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (3) , 696-703
Intracholecystic papillary-tubular neoplasm diagnosed by peroral cholangioscopy
- 10 April 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (3) , 696-703
Intracholecystic papillary-tubular neoplasm diagnosed by peroral cholangioscopy
- 15 February 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (2) , 435-440
Long-term survival in a patient with BRCA2-mutated pleomorphic anaplastic pancreatic carcinoma treated with Olaparib maintenance therapy
- 15 February 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (2) , 435-440
Long-term survival in a patient with BRCA2-mutated pleomorphic anaplastic pancreatic carcinoma treated with Olaparib maintenance therapy
- Open Access
- 15 November 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (22) , 3226-3231
Amyloidosis as an Atypical Cause of Biliary Stricture Diagnosed by Cholangioscopy
Amyloidosis is a rare cause of common bile duct (CBD) stricture that often presents with nonspecific symptoms. We herein report the case of a 61-year-old woman with CBD stricture caused by amyloidosis diagnosed through cholangioscopy and confirmed by a biopsy, with subsequent findings identifying it as AA-type amyloidosis. This condition poses diagnostic challenges owing to its rarity and non-specific manifestations. When common causes are excluded, amyloidosis should be considered in the differential diagnosis of CBD stricture. Advanced imaging and cholangioscopy with targeted biopsies are essential for making an accurate diagnosis. Documenting such cases and further research are vital to improve the understanding and management of amyloidosis-related biliary stricture.
- 15 November 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (22) , 3226-3231
Open AccessAmyloidosis as an Atypical Cause of Biliary Stricture Diagnosed by Cholangioscopy
Amyloidosis is a rare cause of common bile duct (CBD) stricture that often presents with nonspecific symptoms. We herein report the case of a 61-year-old woman with CBD stricture caused by amyloidosis diagnosed through cholangioscopy and confirmed by a biopsy, with subsequent findings identifying it as AA-type amyloidosis. This condition poses diagnostic challenges owing to its rarity and non-specific manifestations. When common causes are excluded, amyloidosis should be considered in the differential diagnosis of CBD stricture. Advanced imaging and cholangioscopy with targeted biopsies are essential for making an accurate diagnosis. Documenting such cases and further research are vital to improve the understanding and management of amyloidosis-related biliary stricture.
- Open Access
Endoscopic Ultrasonography‐guided Variceal Therapy as Salvage Treatment for Rebleeding From Duodenal Varices Following Balloon‐occluded Retrograde Transvenous Obliteration
Duodenal varices, though rare, are potentially life‐threatening complications of portal hypertension. Management is challenging when balloon‐occluded retrograde transvenous obliteration (BRTO) fails to achieve complete obliteration. Endoscopic ultrasonography‐guided variceal therapy (EUS‐VT) is effective for gastric varices, but reports of duodenal varices remain limited. We present a case of a 71‐year‐old woman with alcoholic liver cirrhosis and duodenal variceal bleeding. Initial hemostasis was achieved with endoscopic variceal ligation, followed by BRTO. However, rebleeding occurred due to incomplete obliteration caused by dual afferent veins. EUS‐VT comprising n‐butyl cyanoacrylate was performed as salvage therapy because of ascites and vascular complexity. Despite technical challenges, EUS‐VT successfully obliterated the varices. Post‐procedural computed tomography showed lipiodol migration into the portal system. No rebleeding or liver dysfunction occurred. Ascites worsened—likely because of BRTO and/or EUS‐VT—but was manageable with low‐dose diuretics. This case highlights EUS‐VT as a feasible option after failed BRTO for duodenal varices. A meticulous technique is essential to preventing glue migration.
Open AccessEndoscopic Ultrasonography‐guided Variceal Therapy as Salvage Treatment for Rebleeding From Duodenal Varices Following Balloon‐occluded Retrograde Transvenous Obliteration
Duodenal varices, though rare, are potentially life‐threatening complications of portal hypertension. Management is challenging when balloon‐occluded retrograde transvenous obliteration (BRTO) fails to achieve complete obliteration. Endoscopic ultrasonography‐guided variceal therapy (EUS‐VT) is effective for gastric varices, but reports of duodenal varices remain limited. We present a case of a 71‐year‐old woman with alcoholic liver cirrhosis and duodenal variceal bleeding. Initial hemostasis was achieved with endoscopic variceal ligation, followed by BRTO. However, rebleeding occurred due to incomplete obliteration caused by dual afferent veins. EUS‐VT comprising n‐butyl cyanoacrylate was performed as salvage therapy because of ascites and vascular complexity. Despite technical challenges, EUS‐VT successfully obliterated the varices. Post‐procedural computed tomography showed lipiodol migration into the portal system. No rebleeding or liver dysfunction occurred. Ascites worsened—likely because of BRTO and/or EUS‐VT—but was manageable with low‐dose diuretics. This case highlights EUS‐VT as a feasible option after failed BRTO for duodenal varices. A meticulous technique is essential to preventing glue migration.
- Open Access
Secondary Aortoduodenal Fistula Diagnosed after Repeated Gastrointestinal Bleeding Episodes in a Patient With Prior Aortic Graft Surgery
Secondary aortoduodenal fistula (sADF) is a rare but life‐threatening complication after aortic graft surgery. Diagnosis is often challenging, particularly when contrast‐enhanced computed tomography (CT) and endoscopy results are inconclusive. We report a case in which diagnosis was challenging due to contrast media allergy and non‐diagnostic endoscopic findings, highlighting the importance of clinical suspicion in such scenarios. A 76‐year‐old man with a history of graft replacement for a ruptured abdominal aortic aneurysm presented with five episodes of gastrointestinal bleeding over 3 months. Despite multiple examinations, no bleeding source was identified. Eventually, after the patient developed hypovolemic shock, contrast‐enhanced CT was performed with informed consent, which revealed contrast extravasation from the aorta into the horizontal portion of the duodenum. Endoscopy subsequently identified an exposed vessel in the same location, confirming the diagnosis of sADF. Endovascular aortic repair was successfully performed. This case underscores the need to consider sADF in patients with aortic grafts who present with recurrent, unexplained gastrointestinal bleeding.
Open AccessSecondary Aortoduodenal Fistula Diagnosed after Repeated Gastrointestinal Bleeding Episodes in a Patient With Prior Aortic Graft Surgery
Secondary aortoduodenal fistula (sADF) is a rare but life‐threatening complication after aortic graft surgery. Diagnosis is often challenging, particularly when contrast‐enhanced computed tomography (CT) and endoscopy results are inconclusive. We report a case in which diagnosis was challenging due to contrast media allergy and non‐diagnostic endoscopic findings, highlighting the importance of clinical suspicion in such scenarios. A 76‐year‐old man with a history of graft replacement for a ruptured abdominal aortic aneurysm presented with five episodes of gastrointestinal bleeding over 3 months. Despite multiple examinations, no bleeding source was identified. Eventually, after the patient developed hypovolemic shock, contrast‐enhanced CT was performed with informed consent, which revealed contrast extravasation from the aorta into the horizontal portion of the duodenum. Endoscopy subsequently identified an exposed vessel in the same location, confirming the diagnosis of sADF. Endovascular aortic repair was successfully performed. This case underscores the need to consider sADF in patients with aortic grafts who present with recurrent, unexplained gastrointestinal bleeding.
- Open Access
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e36224
Difficulty in the diagnosis of pancreatic cancer based on the initial CT report: A retrospective study
The role of computed tomography (CT) in the initial diagnosis of pancreatic cancer (PC) is well-known. CT reports made by radiologists are important as not all patients with PC are examined by specialists; however, some cases are not identified based on CT reports. Diagnosis via imaging of PC is sometimes difficult, and the diagnostic rate of PC and other pancreatic diseases can vary across radiologists. This study aimed to examine the diagnostic rate of PC in initial CT reports and the details of cases with diagnostic difficulties. This single-centered, retrospective study collected clinical data of 198 patients with histologically diagnosed PC between January 2018 and April 2022. Out of these contrast-enhanced CT was performed in 192 cases. PC was not reported as the main diagnosis in 18 patients (9.4%; 11 men and 7 women). Among these 18 cases, intrapancreatic mass lesions were detected in 3 (1.6%), indirect findings such as bile/pancreatic duct stenosis or dilation were detected in 5 (2.6%), and no PC-related findings were found in 10 (5.2%). The specialists suspected PC in 15 of these 18 cases based on initial CT reports. 17 cases were confirmed by endoscopic ultrasound-fine needle aspiration and one by biopsy after upper gastrointestinal endoscopy. To improve accuracy of its diagnosis, it is important that specialists provide feedback to diagnostic radiologists regarding the findings they did not report. Endoscopic ultrasound-fine needle aspiration should be performed by specialists when there is clinical information which indicates pancreatic disease of any kind.
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e36224
Open AccessDifficulty in the diagnosis of pancreatic cancer based on the initial CT report: A retrospective study
The role of computed tomography (CT) in the initial diagnosis of pancreatic cancer (PC) is well-known. CT reports made by radiologists are important as not all patients with PC are examined by specialists; however, some cases are not identified based on CT reports. Diagnosis via imaging of PC is sometimes difficult, and the diagnostic rate of PC and other pancreatic diseases can vary across radiologists. This study aimed to examine the diagnostic rate of PC in initial CT reports and the details of cases with diagnostic difficulties. This single-centered, retrospective study collected clinical data of 198 patients with histologically diagnosed PC between January 2018 and April 2022. Out of these contrast-enhanced CT was performed in 192 cases. PC was not reported as the main diagnosis in 18 patients (9.4%; 11 men and 7 women). Among these 18 cases, intrapancreatic mass lesions were detected in 3 (1.6%), indirect findings such as bile/pancreatic duct stenosis or dilation were detected in 5 (2.6%), and no PC-related findings were found in 10 (5.2%). The specialists suspected PC in 15 of these 18 cases based on initial CT reports. 17 cases were confirmed by endoscopic ultrasound-fine needle aspiration and one by biopsy after upper gastrointestinal endoscopy. To improve accuracy of its diagnosis, it is important that specialists provide feedback to diagnostic radiologists regarding the findings they did not report. Endoscopic ultrasound-fine needle aspiration should be performed by specialists when there is clinical information which indicates pancreatic disease of any kind.
- Open Access
- 17 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (46) , e34951
Exploration of predictors associated with bleeding in computed tomography-guided core needle splenic biopsy: A retrospective study
Splenic diseases may be caused by infections and can be either malignant, such as lymphoma and lung cancer, or benign, such as hemangioma. In some cases, diagnostic uncertainty of imaging persists, and image-guided splenic needle biopsy is a useful diagnostic tool to avoid the disadvantages of incorrect diagnosis, including performing unnecessary splenectomy or not giving the necessary treatment. Splenic biopsies can be divided into ultrasound-guided, computed tomography (CT)-guided fine-needle aspiration, or core needle biopsy (CNB). However, few studies have focused exclusively on complications associated with CT-guided CNB of the spleen. Therefore, we assessed bleeding, the most common complication of CT-guided CNB of the spleen, and evaluated factors associated with the bleeding. Using the biopsy database maintained at the institution, all patients who underwent CT-guided CNB of the spleen between May 2012 and September 2022 were identified retrospectively. The 18 identified patients were divided into post-biopsy bleeding and non-bleeding groups for analysis. In total, 17 patients (94.4%) could be diagnosed accurately with CT-guided CNB. Bleeding complications occurred in 7 cases of CT-guided CNB; of these, 2 patients with Common Terminology Criteria for Adverse Events grade 4 disease required transcatheter arterial embolization. The bleeding group was characterized by diffuse spleen tumors in all cases, with significantly more diffuse spleen tumors than the non-bleeding group. CT-guided CNB is a useful option for neoplastic lesions of the spleen that are difficult to diagnose using imaging alone. However, consideration should be given to post-biopsy bleeding in patients with diffuse splenic tumors.
- 17 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (46) , e34951
Open AccessExploration of predictors associated with bleeding in computed tomography-guided core needle splenic biopsy: A retrospective study
Splenic diseases may be caused by infections and can be either malignant, such as lymphoma and lung cancer, or benign, such as hemangioma. In some cases, diagnostic uncertainty of imaging persists, and image-guided splenic needle biopsy is a useful diagnostic tool to avoid the disadvantages of incorrect diagnosis, including performing unnecessary splenectomy or not giving the necessary treatment. Splenic biopsies can be divided into ultrasound-guided, computed tomography (CT)-guided fine-needle aspiration, or core needle biopsy (CNB). However, few studies have focused exclusively on complications associated with CT-guided CNB of the spleen. Therefore, we assessed bleeding, the most common complication of CT-guided CNB of the spleen, and evaluated factors associated with the bleeding. Using the biopsy database maintained at the institution, all patients who underwent CT-guided CNB of the spleen between May 2012 and September 2022 were identified retrospectively. The 18 identified patients were divided into post-biopsy bleeding and non-bleeding groups for analysis. In total, 17 patients (94.4%) could be diagnosed accurately with CT-guided CNB. Bleeding complications occurred in 7 cases of CT-guided CNB; of these, 2 patients with Common Terminology Criteria for Adverse Events grade 4 disease required transcatheter arterial embolization. The bleeding group was characterized by diffuse spleen tumors in all cases, with significantly more diffuse spleen tumors than the non-bleeding group. CT-guided CNB is a useful option for neoplastic lesions of the spleen that are difficult to diagnose using imaging alone. However, consideration should be given to post-biopsy bleeding in patients with diffuse splenic tumors.
- Open Access
- 22 June 2023
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 32 (2) , 216-221
Endoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study
Background and Aims: Endoscopic papillary balloon dilation (EPBD), a low-risk procedure for bleeding, hasbeen suggested as an alternative to endoscopic sphincterotomy for papillary dilatation in patients undergoingendoscopic stone removal who are at a higher risk of bleeding. Several guidelines recommend that combinationof two antiplatelet agents should be reduced to single antiplatelet therapy when endoscopic sphincterotomyis performed. However, there is no evidence that EPBD affects the risk of bleeding in patients receiving acombination of two antiplatelet agents; thus, we aimed to explore this problem. Methods: We included 31 patients who underwent EPBD for common bile duct stones at our hospital fromMay 2014 to August 2022 and received either a combination of two antiplatelet agents or single antiplatelettherapy prior to the procedure. The group receiving a combination of two antiplatelet agents included patientswho underwent EPBT without antiplatelet therapy withdrawal or with a shorter withdrawal period than thoserecommended by the guidelines. Results: In the group that received a combination of two antiplatelet agents, one of the two antiplateletagents used was thienopyridine. No bleeding was observed after EPBD in this study. We did not findany significant between-group differences in hemoglobin levels and rate of post-endoscopic retrogradecholangiopancreatography pancreatitis. Conclusions: In patients treated with a combination of two antiplatelet agents, EPBD could be safely performedwithout bleeding. Therefore, future prospective studies are warranted.
- 22 June 2023
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 32 (2) , 216-221
Open AccessEndoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study
Background and Aims: Endoscopic papillary balloon dilation (EPBD), a low-risk procedure for bleeding, hasbeen suggested as an alternative to endoscopic sphincterotomy for papillary dilatation in patients undergoingendoscopic stone removal who are at a higher risk of bleeding. Several guidelines recommend that combinationof two antiplatelet agents should be reduced to single antiplatelet therapy when endoscopic sphincterotomyis performed. However, there is no evidence that EPBD affects the risk of bleeding in patients receiving acombination of two antiplatelet agents; thus, we aimed to explore this problem. Methods: We included 31 patients who underwent EPBD for common bile duct stones at our hospital fromMay 2014 to August 2022 and received either a combination of two antiplatelet agents or single antiplatelettherapy prior to the procedure. The group receiving a combination of two antiplatelet agents included patientswho underwent EPBT without antiplatelet therapy withdrawal or with a shorter withdrawal period than thoserecommended by the guidelines. Results: In the group that received a combination of two antiplatelet agents, one of the two antiplateletagents used was thienopyridine. No bleeding was observed after EPBD in this study. We did not findany significant between-group differences in hemoglobin levels and rate of post-endoscopic retrogradecholangiopancreatography pancreatitis. Conclusions: In patients treated with a combination of two antiplatelet agents, EPBD could be safely performedwithout bleeding. Therefore, future prospective studies are warranted.
- Open Access
- 22 October 2022
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30587
Severe Generalized Epidemic Myalgia in an Adult due to Human Parechovirus Type 3: A Case Report
Parechovirus A type 3 (PeVA3) is most commonly transmitted to adults from children. Although PeVA3 infection is rarely diagnosed, as the symptoms are generally mild and self-limiting, this infection has been associated with epidemic myalgia in Japan. The patient, a 37-year-old man, presented with severe generalized myalgia, inability to open his mouth, and orchitis, which resolved over a period of 10 days. All members of his family were thought to have been infected with PeVA3 during a visit to an amusement park. Although the source of infection and inability to open his mouth are atypical, the acute generalized muscle symptoms made us suspect epidemic myalgia and enabled us to make a diagnosis of PeVA3 infection.
- 22 October 2022
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30587
Open AccessSevere Generalized Epidemic Myalgia in an Adult due to Human Parechovirus Type 3: A Case Report
Parechovirus A type 3 (PeVA3) is most commonly transmitted to adults from children. Although PeVA3 infection is rarely diagnosed, as the symptoms are generally mild and self-limiting, this infection has been associated with epidemic myalgia in Japan. The patient, a 37-year-old man, presented with severe generalized myalgia, inability to open his mouth, and orchitis, which resolved over a period of 10 days. All members of his family were thought to have been infected with PeVA3 during a visit to an amusement park. Although the source of infection and inability to open his mouth are atypical, the acute generalized muscle symptoms made us suspect epidemic myalgia and enabled us to make a diagnosis of PeVA3 infection.